Leukemia Clinical Trials

Showing 6061-6080 of 8,366 trials

COMPLETEDPhase 1/2

Phase I/II Trial to Evaluate Safety, Tolerability and Pharmacokinetic Profile of HM61713 in NSCLC Patients

NCT01588145

The main objective of this study is to evaluate the safety and tolerability of HM61713.

Non Small Cell Lung Cancer

Hanmi Pharmaceutical Company Limited273 participantsStarted Mar 2012

Seoul, South Korea

COMPLETEDPhase 2

Bortezomib for Low or Intermediate-1 Myelodysplastic Syndrome (MDS) With p65 Activation

NCT01891968

The goal of this clinical research study is to learn if bortezomib can help to control MDS. The safety of this drug will also be studied. Bortezomib is designed to block a protein that causes cells to grow. This may cause cancer cells to die.

Leukemia

M.D. Anderson Cancer Center15 participantsStarted Aug 2013

Houston, Texas, United States

COMPLETEDPhase 1

Bortezomib and Romidepsin in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

NCT00963274

This phase I trial studies the side effects and best dose of giving bortezomib and romidepsin together in treating patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), indolent B-cell lymphoma, peripheral T-cell lymphoma (PTCL) or cutaneous T-cell lymphoma (CTCL). Bortezomib and romidepsin may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth.

LeukemiaLymphoma

Virginia Commonwealth University18 participantsStarted Apr 2010

Chicago, Illinois, United States • Baltimore, Maryland, United States • Chapel Hill, North Carolina, United States +2 more locations

Phase I/II Trial to Evaluate Safety, Tolerability and Pharmacokinetic Profile of HM61713 in NSCLC Patients

Bortezomib for Low or Intermediate-1 Myelodysplastic Syndrome (MDS) With p65 Activation

Bortezomib and Romidepsin in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Related Searches

Broncho-Adventitial Delivery of Paclitaxel to Extend Airway Patency in Malignant Airway Obstruction Patients

Short Course Radiation Therapy in Palliative Treatment of Complicated Bone Metastases

Lapatinib in Treating Patients With Locally Advanced or Metastatic Biliary Tract or Liver Cancer That Cannot Be Removed By Surgery

Concurrent Chemoradiotherapy With Famitinib for Patients With Locally Advanced Nasopharyngeal Carcinoma

Evaluation of a New HIV Prevention Intervention for Black Bisexually-active Men

Pulmonary Interstitial Lymphography in Early Stage Lung Cancer

Precise Treatment System of Biliary Malignancies Based on Special Disease Database

Once-Daily Investigational Nasal Spray In Adults And Adolescents With Perennial Allergic Rhinitis (PAR)

AZD2171 and Pemetrexed Disodium in Treating Patients With Relapsed Non-Small Cell Lung Cancer

Decitabine and Cytarabine in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia, High Risk Myelodysplastic Syndrome, or Myeloproliferative Neoplasm

Innate Neutrophilic Nasal Inflammation in a Pollen Exposure Chamber

Immunochemoradiotherapy in Patients With Pancreatic Cancer

Vorinostat in Children

Trabectedin First Line Therapy In Unfit Sarcoma Study

Low Dose Exposure to Oxidized R-limonene - A Repeated Open Application Test (ROAT) Study

A Trial of Intravenous Denileukin Diftitox Plus Subcutaneous Pegylated IFNα-2A in Stage III or IV Ovarian Cancer

Three Dimension Laparoscopic Versus Open Surgery for Gallbladder Carcinoma